STERIS plc reported $6.04B of revenue over the trailing twelve months, +8.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.04B (to Q1 2027). Net income: $805M, trailing twelve months to Q1 2027. Free cash flow: $926M, trailing twelve months to Q1 2027. Operating margin: 19%, trailing twelve months to Q1 2027.

STESTERIS plc

Healthcare

$214.44-14% 1Y

$214.44

$199.4052 weeks$267.17

STE as reported

STERIS plc reported $6.04B of revenue over the trailing twelve months, +8.4% on the year before. 11 reported series are charted on this page, each one as filed.

$6.04B

Revenue, trailing twelve months · to Q1 2027 · +8.4% against the twelve months before

Net income: $805M
Net income · +25% year on year · trailing twelve months to Q1 2027
Free cash flow: $926M
Free cash flow · +1.8% year on year · trailing twelve months to Q1 2027
Operating margin: 19%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for STE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.04B	+8.4%	Q1 2027
Net income	$805M	+25%	Q1 2027
EPS	$8.18	+25%	Q1 2027
Gross margin	44%	n/a	Q1 2027
Operating margin	19%	n/a	Q1 2027
Net margin	13%	n/a	Q1 2027
ROE	10%	n/a	Q1 2027
ROA	7.0%	n/a	Q1 2027
ROIC	9.7%	n/a	Q1 2027
Free cash flow	$926M	+1.8%	Q1 2027
P/E	26.2	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.